Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 149038 entries
Sorted by: Best Match Show Resources per page
Efficacy of prophylactic epidural ketamine for reducing shivering in patients undergoing caesarean section with combined spinal-epidural anesthesia.

Biomedical reports

Xue X, Lv Y, Zhao Y, Leng Y, Zhang Y.
PMID: 29732150
Biomed Rep. 2018 May;8(5):485-490. doi: 10.3892/br.2018.1072. Epub 2018 Mar 07.

Intravenous ketamine is known to inhibit postoperative shivering; however, at present, there has been little research on whether this effect may be achieved with epidural application. The aim of the present study was to evaluate the efficacy and safety...

Cite
Xue X, Lv Y, Zhao Y, et al. Efficacy of prophylactic epidural ketamine for reducing shivering in patients undergoing caesarean section with combined spinal-epidural anesthesia. Biomed Rep. 2018;8(5):485-490doi: 10.3892/br.2018.1072.
Xue, X., Lv, Y., Zhao, Y., Leng, Y., & Zhang, Y. (2018). Efficacy of prophylactic epidural ketamine for reducing shivering in patients undergoing caesarean section with combined spinal-epidural anesthesia. Biomedical reports, 8(5), 485-490. https://doi.org/10.3892/br.2018.1072
Xue, Xing, et al. "Efficacy of prophylactic epidural ketamine for reducing shivering in patients undergoing caesarean section with combined spinal-epidural anesthesia." Biomedical reports vol. 8,5 (2018): 485-490. doi: https://doi.org/10.3892/br.2018.1072
Xue X, Lv Y, Zhao Y, Leng Y, Zhang Y. Efficacy of prophylactic epidural ketamine for reducing shivering in patients undergoing caesarean section with combined spinal-epidural anesthesia. Biomed Rep. 2018 May;8(5):485-490. doi: 10.3892/br.2018.1072. Epub 2018 Mar 07. PMID: 29732150; PMCID: PMC5920941.
Copy Download .nbib Format: NLM
The Comprehensive Heart Failure Centre in Würzburg, Germany.

European heart journal

Angermann CE, Frantz S, Maack C.
PMID: 29788301
Eur Heart J. 2018 May 21;39(20):1757-1760. doi: 10.1093/eurheartj/ehy202.

No abstract available.

Cite
Angermann CE, Frantz S, Maack C. The Comprehensive Heart Failure Centre in Würzburg, Germany. Eur Heart J. 2018;39(20):1757-1760doi: 10.1093/eurheartj/ehy202.
Angermann, C. E., Frantz, S., & Maack, C. (2018). The Comprehensive Heart Failure Centre in Würzburg, Germany. European heart journal, 39(20), 1757-1760. https://doi.org/10.1093/eurheartj/ehy202
Angermann, Christiane E, et al. "The Comprehensive Heart Failure Centre in Würzburg, Germany." European heart journal vol. 39,20 (2018): 1757-1760. doi: https://doi.org/10.1093/eurheartj/ehy202
Angermann CE, Frantz S, Maack C. The Comprehensive Heart Failure Centre in Würzburg, Germany. Eur Heart J. 2018 May 21;39(20):1757-1760. doi: 10.1093/eurheartj/ehy202. PMID: 29788301.
Copy Download .nbib Format: NLM
Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study.

Journal of bone oncology

Wilson C, Martin C, Winter MC.
PMID: 30937280
J Bone Oncol. 2019 Feb 19;15:100226. doi: 10.1016/j.jbo.2019.100226. eCollection 2019 Apr.

BACKGROUND: Adjuvant bisphosphonates (BPs) are recommended as part of routine early breast cancer treatment for many postmenopausal (PM) women within the past year. There is a paucity of 'real world' data on compliance and patient satisfaction with oral BPs...

Cite
Wilson C, Martin C, Winter MC. Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study. J Bone Oncol. 2019;15:100226doi: 10.1016/j.jbo.2019.100226.
Wilson, C., Martin, C., & Winter, M. C. (2019). Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study. Journal of bone oncology, 15100226. https://doi.org/10.1016/j.jbo.2019.100226
Wilson, C, et al. "Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study." Journal of bone oncology vol. 15 (2019): 100226. doi: https://doi.org/10.1016/j.jbo.2019.100226
Wilson C, Martin C, Winter MC. Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study. J Bone Oncol. 2019 Feb 19;15:100226. doi: 10.1016/j.jbo.2019.100226. eCollection 2019 Apr. PMID: 30937280; PMCID: PMC6429539.
Copy Download .nbib Format: NLM
3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart.

Biomedical optics express

Zickus V, Taylor JM.
PMID: 29760998
Biomed Opt Express. 2018 Apr 27;9(5):2418-2435. doi: 10.1364/BOE.9.002418. eCollection 2018 May 01.

We present SPIM-μPIV as a flow imaging system, capable of measuring

Cite
Zickus V, Taylor JM. 3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart. Biomed Opt Express. 2018;9(5):2418-2435doi: 10.1364/BOE.9.002418.
Zickus, V., & Taylor, J. M. (2018). 3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart. Biomedical optics express, 9(5), 2418-2435. https://doi.org/10.1364/BOE.9.002418
Zickus, Vytautas, and Taylor, Jonathan M. "3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart." Biomedical optics express vol. 9,5 (2018): 2418-2435. doi: https://doi.org/10.1364/BOE.9.002418
Zickus V, Taylor JM. 3D + time blood flow mapping using SPIM-microPIV in the developing zebrafish heart. Biomed Opt Express. 2018 Apr 27;9(5):2418-2435. doi: 10.1364/BOE.9.002418. eCollection 2018 May 01. PMID: 29760998; PMCID: PMC5946799.
Copy Download .nbib Format: NLM
Preserved endothelial function in young adults with type 1 diabetes.

PloS one

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K.
PMID: 30359432
PLoS One. 2018 Oct 25;13(10):e0206523. doi: 10.1371/journal.pone.0206523. eCollection 2018.

BACKGROUND AND AIM: Endothelial dysfunction is involved in the pathogenesis of atherosclerosis and is typically present in older adults with type 1 diabetes (T1D). In young adults, we aimed to assess the impact of T1D on endothelial function as...

Cite
Heier M, Espeland CN, Brunborg C, et al. Preserved endothelial function in young adults with type 1 diabetes. PLoS One. 2018;13(10):e0206523doi: 10.1371/journal.pone.0206523.
Heier, M., Espeland, C. N., Brunborg, C., Seljeflot, I., Margeirsdottir, H. D., Hanssen, K. F., Fugelseth, D., & Dahl-Jørgensen, K. (2018). Preserved endothelial function in young adults with type 1 diabetes. PloS one, 13(10), e0206523. https://doi.org/10.1371/journal.pone.0206523
Heier, Martin, et al. "Preserved endothelial function in young adults with type 1 diabetes." PloS one vol. 13,10 (2018): e0206523. doi: https://doi.org/10.1371/journal.pone.0206523
Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K. Preserved endothelial function in young adults with type 1 diabetes. PLoS One. 2018 Oct 25;13(10):e0206523. doi: 10.1371/journal.pone.0206523. eCollection 2018. PMID: 30359432; PMCID: PMC6201945.
Copy Download .nbib Format: NLM
Exercise self-efficacy in adults with congenital heart disease.

International journal of cardiology. Heart & vasculature

Bay A, Sandberg C, Thilén U, Wadell K, Johansson B.
PMID: 29349286
Int J Cardiol Heart Vasc. 2018 Jan 12;18:7-11. doi: 10.1016/j.ijcha.2017.12.002. eCollection 2018 Mar.

BACKGROUND: Physical activity improves health, exercise tolerance and quality of life in adults with congenital heart disease (CHD), and exercise training is in most patients a high-benefit low risk intervention. However, factors that influence the confidence to perform exercise...

Cite
Bay A, Sandberg C, Thilén U, et al. Exercise self-efficacy in adults with congenital heart disease. Int J Cardiol Heart Vasc. 2018;18:7-11doi: 10.1016/j.ijcha.2017.12.002.
Bay, A., Sandberg, C., Thilén, U., Wadell, K., & Johansson, B. (2018). Exercise self-efficacy in adults with congenital heart disease. International journal of cardiology. Heart & vasculature, 187-11. https://doi.org/10.1016/j.ijcha.2017.12.002
Bay, Annika, et al. "Exercise self-efficacy in adults with congenital heart disease." International journal of cardiology. Heart & vasculature vol. 18 (2018): 7-11. doi: https://doi.org/10.1016/j.ijcha.2017.12.002
Bay A, Sandberg C, Thilén U, Wadell K, Johansson B. Exercise self-efficacy in adults with congenital heart disease. Int J Cardiol Heart Vasc. 2018 Jan 12;18:7-11. doi: 10.1016/j.ijcha.2017.12.002. eCollection 2018 Mar. PMID: 29349286; PMCID: PMC5767904.
Copy Download .nbib Format: NLM
Correction: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells.

Leukemia

Adamiak M, Bujko K, Cymer M, Plonka M, Glaser T, Kucia M, Ratajczak J, Ulrich H, Abdel-Latif A, Ratajczak MZ.
PMID: 30846863
Leukemia. 2019 Apr;33(4):1057. doi: 10.1038/s41375-019-0407-y.

Following the publication of this article, the authors noted that the following should be included in the Acknowledgements section: "MA is the recipient of a START scholarship (0785) from FNP". The authors wish to apologise for any inconvenience caused.

Cite
Adamiak M, Bujko K, Cymer M, et al. Correction: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia. 2019;33(4):1057doi: 10.1038/s41375-019-0407-y.
Adamiak, M., Bujko, K., Cymer, M., Plonka, M., Glaser, T., Kucia, M., Ratajczak, J., Ulrich, H., Abdel-Latif, A., & Ratajczak, M. Z. (2019). Correction: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia, 33(4), 1057. https://doi.org/10.1038/s41375-019-0407-y
Adamiak, Mateusz, et al. "Correction: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells." Leukemia vol. 33,4 (2019): 1057. doi: https://doi.org/10.1038/s41375-019-0407-y
Adamiak M, Bujko K, Cymer M, Plonka M, Glaser T, Kucia M, Ratajczak J, Ulrich H, Abdel-Latif A, Ratajczak MZ. Correction: Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia. 2019 Apr;33(4):1057. doi: 10.1038/s41375-019-0407-y. PMID: 30846863; PMCID: PMC7608283.
Copy Download .nbib Format: NLM
Heart Rate Variability and Pulse Pressure Amplification: Lessons from Diabetic Patients.

Pulse (Basel, Switzerland)

Laucyte-Cibulskiene A.
PMID: 29761087
Pulse (Basel). 2018 Mar;5(1):125-126. doi: 10.1159/000480035. Epub 2017 Oct 25.

No abstract available.

Cite
Laucyte-Cibulskiene A. Heart Rate Variability and Pulse Pressure Amplification: Lessons from Diabetic Patients. Pulse (Basel). 2017;5(1):125-126doi: 10.1159/000480035.
Laucyte-Cibulskiene, A. (2018). Heart Rate Variability and Pulse Pressure Amplification: Lessons from Diabetic Patients. Pulse (Basel, Switzerland), 5(1), 125-126. https://doi.org/10.1159/000480035
Laucyte-Cibulskiene, Agne. "Heart Rate Variability and Pulse Pressure Amplification: Lessons from Diabetic Patients." Pulse (Basel, Switzerland) vol. 5,1 (2018): 125-126. doi: https://doi.org/10.1159/000480035
Laucyte-Cibulskiene A. Heart Rate Variability and Pulse Pressure Amplification: Lessons from Diabetic Patients. Pulse (Basel). 2018 Mar;5(1):125-126. doi: 10.1159/000480035. Epub 2017 Oct 25. PMID: 29761087; PMCID: PMC5939698.
Copy Download .nbib Format: NLM
Improved Teamwork and Implementation of Clinical Pathways in a Congenital Heart Surgery Program.

Pediatric quality & safety

Willis TS, Yip T, Brown K, Buck S, Mill M.
PMID: 30937408
Pediatr Qual Saf. 2019 Jan 18;4(1):e126. doi: 10.1097/pq9.0000000000000126. eCollection 2019.

INTRODUCTION: Complex surgical populations are at increased risk of morbidity, especially when experiencing variations in care and poor teamwork. The goal of this project was to improve teamwork and decrease variations in care in a pediatric congenital heart surgery...

Cite
Willis TS, Yip T, Brown K, et al. Improved Teamwork and Implementation of Clinical Pathways in a Congenital Heart Surgery Program. Pediatr Qual Saf. 2019;4(1):e126doi: 10.1097/pq9.0000000000000126.
Willis, T. S., Yip, T., Brown, K., Buck, S., & Mill, M. (2019). Improved Teamwork and Implementation of Clinical Pathways in a Congenital Heart Surgery Program. Pediatric quality & safety, 4(1), e126. https://doi.org/10.1097/pq9.0000000000000126
Willis, Tina Schade, et al. "Improved Teamwork and Implementation of Clinical Pathways in a Congenital Heart Surgery Program." Pediatric quality & safety vol. 4,1 (2019): e126. doi: https://doi.org/10.1097/pq9.0000000000000126
Willis TS, Yip T, Brown K, Buck S, Mill M. Improved Teamwork and Implementation of Clinical Pathways in a Congenital Heart Surgery Program. Pediatr Qual Saf. 2019 Jan 18;4(1):e126. doi: 10.1097/pq9.0000000000000126. eCollection 2019. PMID: 30937408; PMCID: PMC6426495.
Copy Download .nbib Format: NLM
Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation.

Child neurology open

Chiu ATG, Chan SHS, Wu SP, Ting SH, Chung BHY, Chan AOK, Wong VCN.
PMID: 29761130
Child Neurol Open. 2018 Apr 19;5:2329048X18769811. doi: 10.1177/2329048X18769811. eCollection 2018.

The authors report a child with spinal muscular atrophy with respiratory distress type 1 (SMARD1). She presented atypically with hypothyroidism and heart failure due to septal defects that required early heart surgery and microcephaly in association with cerebral atrophy...

Cite
Chiu ATG, Chan SHS, Wu SP, et al. Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation. Child Neurol Open. 2018;5:2329048X18769811doi: 10.1177/2329048X18769811.
Chiu, A. T. G., Chan, S. H. S., Wu, S. P., Ting, S. H., Chung, B. H. Y., Chan, A. O. K., & Wong, V. C. N. (2018). Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation. Child neurology open, 52329048X18769811. https://doi.org/10.1177/2329048X18769811
Chiu, Annie Ting Gee, et al. "Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation." Child neurology open vol. 5 (2018): 2329048X18769811. doi: https://doi.org/10.1177/2329048X18769811
Chiu ATG, Chan SHS, Wu SP, Ting SH, Chung BHY, Chan AOK, Wong VCN. Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation. Child Neurol Open. 2018 Apr 19;5:2329048X18769811. doi: 10.1177/2329048X18769811. eCollection 2018. PMID: 29761130; PMCID: PMC5946598.
Copy Download .nbib Format: NLM
PhysioZoo: A Novel Open Access Platform for Heart Rate Variability Analysis of Mammalian Electrocardiographic Data.

Frontiers in physiology

Behar JA, Rosenberg AA, Weiser-Bitoun I, Shemla O, Alexandrovich A, Konyukhov E, Yaniv Y.
PMID: 30337883
Front Physiol. 2018 Oct 04;9:1390. doi: 10.3389/fphys.2018.01390. eCollection 2018.

No abstract available.

Cite
Behar JA, Rosenberg AA, Weiser-Bitoun I, et al. PhysioZoo: A Novel Open Access Platform for Heart Rate Variability Analysis of Mammalian Electrocardiographic Data. Front Physiol. 2018;9:1390doi: 10.3389/fphys.2018.01390.
Behar, J. A., Rosenberg, A. A., Weiser-Bitoun, I., Shemla, O., Alexandrovich, A., Konyukhov, E., & Yaniv, Y. (2018). PhysioZoo: A Novel Open Access Platform for Heart Rate Variability Analysis of Mammalian Electrocardiographic Data. Frontiers in physiology, 91390. https://doi.org/10.3389/fphys.2018.01390
Behar, Joachim A, et al. "PhysioZoo: A Novel Open Access Platform for Heart Rate Variability Analysis of Mammalian Electrocardiographic Data." Frontiers in physiology vol. 9 (2018): 1390. doi: https://doi.org/10.3389/fphys.2018.01390
Behar JA, Rosenberg AA, Weiser-Bitoun I, Shemla O, Alexandrovich A, Konyukhov E, Yaniv Y. PhysioZoo: A Novel Open Access Platform for Heart Rate Variability Analysis of Mammalian Electrocardiographic Data. Front Physiol. 2018 Oct 04;9:1390. doi: 10.3389/fphys.2018.01390. eCollection 2018. PMID: 30337883; PMCID: PMC6180147.
Copy Download .nbib Format: NLM
Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.

JCO precision oncology

Liu X, Yue Z, Cao Y, Taylor L, Zhang Q, Choi SW, Hanash S, Ito S, Chen JY, Wu H, Paczesny S.
PMID: 31406955
JCO Precis Oncol. 2019;3. doi: 10.1200/po.18.00365. Epub 2019 May 23.

PURPOSE: As a tumor immunotherapy, allogeneic hematopoietic cell transplantation with subsequent donor lymphocyte injection (DLI) aims to induce the graft-versus-tumor (GVT) effect but often also leads to acute graft-versus-host disease (GVHD). Plasma tests that can predict the likelihood of...

Cite
Liu X, Yue Z, Cao Y, et al. Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. JCO Precis Oncol. 2019;3doi: 10.1200/po.18.00365.
Liu, X., Yue, Z., Cao, Y., Taylor, L., Zhang, Q., Choi, S. W., Hanash, S., Ito, S., Chen, J. Y., Wu, H., & Paczesny, S. (2019). Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. JCO precision oncology, 3. https://doi.org/10.1200/po.18.00365
Liu, Xiaowen, et al. "Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology." JCO precision oncology vol. 3 (2019). doi: https://doi.org/10.1200/po.18.00365
Liu X, Yue Z, Cao Y, Taylor L, Zhang Q, Choi SW, Hanash S, Ito S, Chen JY, Wu H, Paczesny S. Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. JCO Precis Oncol. 2019;3. doi: 10.1200/po.18.00365. Epub 2019 May 23. PMID: 31406955; PMCID: PMC6690359.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 149038 entries